drugset / Trial / NCT01499069
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
NaSingle-groupOpen-labelOther
Summary
Nerve growth factor (NGF), prostaglandin E2 (PGE2)and adenosine triphosphate (ATP) levels in urine were reported to increase in patients with overactive bladder (OAB). Also, administration of the anti-muscarinic agent was reported to decrease urinary NGF and ATP. The investigators aimed to explore the value of the urinary NGF, PGE2 and ATP as biomarker for predicting the treatment responsiveness and symptom relapse in OAB patients. So, the patients can be categorized into responder or non- responder and relapse or non-relapse groups. Ultimately, they can receive individualized treatments.
Timeline
- Start
- 2010-02
- Primary completion
- 2015-11
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | — | — |
| Subject | Oxybutinin | Unknown | — | — |
| Subject | Propiverin | Unknown | — | — |
| Subject | Solifenacin | Small molecule | — | — |
| Subject | Trospium | Small molecule | — | — |